Corporate History
| 1965 | Nihon Iyakuhin Kogyo Co., Ltd. established |
|---|---|
| 1967 | Completed the plant to produce pharmaceutical tablets and powder in Toyama City, followed by the completion of the plant to produce injection drugs. |
| 1970 | Completed Namerikawa Plant in Namerikawa City |
| 1972 | Completed Research Institute on Toyama Plant premises |
| 1974 | Completed Head Office Building in Sogawa, Toyama City |
| 1980 | Listed on Nagoya Stock Exchange, Second mp4 |
| 1981 | Listed on Osaka Stock Exchange, Second mp4 |
| 1983 | Completed new GLP-compliant Research Institute adjacent to Namerikawa Plant |
| 1985 | Established Tokyo Branch Office Building in Bunkyo Ward, Tokyo |
| 1986 | Completed Fukuno Plant (now Nanto) in Fukunomachi, Higashi Tonamigun, Toyama Prefecture |
| 1987 | Launched SEDAPAIN Injection as new proprietary drug, a central nervous system analgesic |
| 1993 | Launched CADEX, a drug to treat pressure ulcer and skin ulcer under foreign license was obtained |
| 1994 | LaucnchedUNICON Tablets, a drug to treat asthma diseases under foreign license |
| 1995 | Established Head Office Annex as the 30th anniversary of company's foundation |
| 1996 | Completed revised GMP-compliant injection plant in Yasuda, Namerikawa City |
| 1997 | Adopted new GPMSP-compliant corporate framework |
| 1998 | Adopted new GCP-compliant corporate framework |
| 2000 | Established MPS (Medical Practice Support) team at all business offices |
| 2001 | Made partially acquisition of OTC business from Japan Tobacco, Inc. Launched FERRUM Capsules, slow-release iron preparation for oral use and synthetic penicillin PENGOOD as Branded Generic Drug. |
| 2003 | Completed Nichi-Iko Distribution Center in Namerikawa City Launched FESIN Injection, iron preparation for I.V. use as Branded Generic Drug. |
| 2004 | Installed new sales support system in the Sales Division. Acquired the sales operation right of Maruko Pharmaceutical Co., Ltd. |
| 2005 | Merged Nihon-Gallen Co., Ltd. Acquired partially the stock of Maruko Pharmaceutical Co., Ltd., who was subsequently the subsidiary of Nichi-Iko Pharmaceutical Co., Ltd. Changed the company name to Nichi-Iko Co., Ltd.(the official registered name in English :Nichi-Iko Pharmaceutical Co., Ltd.) Acquired partially the stock of Oriental Pharmaceutical Co., Ltd., who was subsequently the subsidiary of Nichi-Iko Pharmaceutical Co., Ltd. |
| 2006 | Completed Pharmaceutical Development Center adjacent to Namerikawa Plant Commenced the operation of Higashi-Nihon Distribution Center Promoted to First mp4 of both Osaka Stock Exchange and Nagoya Stock Exchange |
| 2007 | Merged with Maruko Pharmaceutical Co., Ltd. to be the wholly owned subsidiary of Nichi-Iko Pharmaceutical Co., Ltd. Dissolved Kobayashi Yakugaku Industry Co., Ltd., one of the subsidiary of Nichi-Iko Pharmaceutical Co., Ltd. |
| 2008 | Merged and Aquired Teikoku Medix Co., Ltd., to be wholly owned subisidiary of Nichi-iko Pharmaceutical Co., Ltd. |
| 2009 | Maruko Pharmaceutical Co., Ltd., Oriental Pharmaceutical Co., Ltd., and Teikoku Medix Co., Ltd. were consolidated to create Nichi-iko Pharma Factory Co., Ltd. Active Pharma Co., Ltd., a manufacturer of Apls for generics, was created as a joint venture company with Mitani Sangyo Co., Ltd. |
| 2010 | Remodeled flagship plant "Pentagon" in Namerikawa city, Toyama started full operation. Established sanofi-aventis Nichi-Iko K.K. by joint capital investment with sanofi-aventis Group (Currently SANOFI) Entered into Full Agency Agreement regarding marketing, sales, distribution and logistics in Hong Kong, Thailand and Malayshia with DKSH. Entered into a capital and business alliance agreement with Aprogen Inc. for research and development of biosimilar products. Listed on the Tokyo Stock Exchange, First mp4. |
| 2011 | Establishment of Nichi-Iko Medical Practice Institute Co., Ltd. Completed Global Development center, Honeycomb building. Delisting from Osaka Stock Exchange and Nagoya Stock Exchange |
| 2012 | Announced the 6th Medium term business plan "Pyramid" Acquired Yakuhan Pharmaceutical Co., Ltd. Merger consolidated subsidiary, Nichi-Iko Pharmaceutical Co., Ltd. Tokyo office became another head quarter and Namerikawa Plant 1& 2 renamed Toyama Plant 1& 2. |
| 2013 | Completed 2nd flagship plant "Pyramid" in Namerikawa city. Merged and Aquired Yakuhan Pharmaceutical Co., Ltd., to be wholly owned subisidiary of Nichi-iko Pharmaceutical Co., Ltd. Established Nichi-Iko Bangkok Representative Office in Thailand Entered into a business alliance with Biolab in Thailand Entered into a basic agreement for business acquisition of Astellas Pharma Group, Fuji Plant Entered into an agreement for capital alliance with Binex in Korea Entered into a business alliance with Hanoi Pharma in Vietnam Issued the Commitment-type Rights Offering (Allotment of Listing-type Stock Acquisition Rights without Contribution) |
| 2014 | Established Nichi-Iko (Thailand) Co., Ltd. as a 100% owned local subsidiary in Thailand Established NIXS Corporation as a 100% owned local subsidiary in USA Launched Nichi-Iko Pharma Tech Co., Ltd. as a consolidated subsidiary |
| 2015 | Entered into a business alliance with Bangkok Lab and Cosmetic in Thailand |
| 2016 | Announced the 7th Medium term business plan "Obelisk" Acquired all outstanding stocks of Sagent Pharmaceuticals, Inc.and made it a wholly owned subsidiary. |
| 2017 | Obtained Marketing Approval for infliximab BS for I.V.Infusion 100mg "Nichi-Iko" Merger consolidated subsidiary, Nichi-Iko Pharma Tech Co., Ltd. |
| 12/13/2017 | Completion of the new formulation facility “Obelisk Building” construction at the site of the Toyama Plant 1. |
| 01/15/2018 | Business alliance agreement with Lloyd Laboratories Inc. and Innogen Pharmaceuticals Inc. (Philippines) |
| 03/28/2018 | Strategic alliance agreement with Eisai Co., Ltd. |
| 07/09/2018 | Business alliance with Sunward Pharmaceutical Pte Ltd. (Singapore) |
| 04/01/2019 | Acquired Elmed Co., Ltd. |
| 11/12/2019 | Concludes business alliance with MedPeer Inc. |
| 02/01/2021 | Acquired all outstanding stocks of Nichi-Iko Gifu Plant Co., Ltd. and made it a wholly owned subsidiary. |